J. Safra Asset Management’s Merck MRK Stock Holding History

J. Safra Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$498K	Buy	4,144 +3,642	+725%	+$420K	0.03%	158
2025 Q4	$52.8K	Buy	502 +52	+12%	+$4.88K	﹤0.01%	279
2025 Q3	$37.8K	Buy	450 +157	+54%	+$12.9K	﹤0.01%	220
2025 Q2	$23.2K	Sell	293 -3,969	-93%	-$315K	﹤0.01%	244
2025 Q1	$383K	Buy	4,262 +1,310	+44%	+$122K	0.03%	90
2024 Q4	$290K	Buy	2,952 +1,709	+137%	+$176K	0.02%	98
2024 Q3	$141K	Buy	1,243 +298	+32%	+$35.4K	0.01%	96
2024 Q2	$117K	Buy	945 +489	+107%	+$63K	0.01%	89
2024 Q1	$60.2K	Sell	456 -1,127	-71%	-$139K	0.01%	76
2023 Q4	$173K	Sell	1,583 -378	-19%	-$39.2K	0.02%	45
2023 Q3	$202K	Hold	1,961	–	–	0.03%	40
2023 Q2	$226K	Hold	1,961	–	–	0.03%	39
2023 Q1	$209K	Hold	1,961	–	–	0.03%	43
2022 Q4	$217K	Buy	+1,961	New	+$200K	0.04%	21
2016 Q3	–	Sell	-926	Closed	-$51K	–	208
2016 Q2	$51K	Sell	926 -7,205	-89%	-$383K	0.08%	91
2016 Q1	$411K	Sell	8,131 -505	-6%	-$24.7K	0.33%	74
2015 Q4	$435K	Buy	+8,636	New	+$435K	0.33%	73

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Safra Asset Management's MRK Position: Q1 2026 in Review

J. Safra Asset Management increased its Merck (MRK) stake by 725% in Q1 2026, buying an estimated $420K and bringing the position to 4,144 shares worth $498K. The position accounts for 0.03% of the portfolio, ranked #158.

J. Safra Asset Management first reported a position in MRK in Q4 2015 and has held it in 17 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

J. Safra Asset Management held 4,144 shares of Merck worth $498K as of Q1 2026.
J. Safra Asset Management bought 3,642 Merck shares in Q1 2026, an estimated $420K.
Merck made up 0.03% of J. Safra Asset Management's portfolio in Q1 2026, its #158 holding.
J. Safra Asset Management first reported a position in Merck in Q4 2015 and has held it in 17 quarters since.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.